Dr. Gordon Smith talks with Dr. Haya Bishara about the association between GBS and both SARS-CoV-2 infection and the COVID-19 vaccine. Show references: https://n.neurology.org/content/early/2023/10/18/WNL.0000000000207900

In the concluding segment of this three-part series, Dr. Irfan Sheikh delves into the landscape of anti-seizure medications. In this last installment, his attention turns to Cannabidiol.

In the second part of this three-part series, Dr. Irfan Sheikh explores the realm of anti-seizure medications. In this installment, he shifts his focus to Perampanel.

In the first segment of a three-part series, Dr. Irfan Sheikh delves into the topic of anti-seizure medications. In today's installment, his focus will be on Cenobamate.

Drs. Divya Singhal and Myriam Abdennadher discuss their paper, "Work, Parenting, and Well-being. An International Survey of Neurologists During the COVID-19 Pandemic"

Show references: https://www.neurology.org/doi/10.1212/cpj.0000000000200176

Dr. Andrew Southerland talks with Dr. Franzi Herpich about her journey of experiencing a stroke in 2021.

Dr. Halley Alexander discusses the paper, "Treatment of seizures in the neonate: Guidelines and consensus-based recommendations-Special report from the ILAE Task Force on Neonatal Seizures".

Show references: https://pubmed.ncbi.nlm.nih.gov/37655702/

Max Goldman, Director of Congressional Affairs at the AAN, gives a year-end advocacy update.

Matt Kerschner, Director of Regulatory Affairs and Policy at the AAN, gives a year-end advocacy update.

Dr. Adam de Havenon talks with Dr. Gustaf Edgren about the potential transmissible risk associated with some types of spontaneous intracerebral hemorrhage in patients who receive transfusions.